Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Efficacy and Safety of TD-1473 in Crohn's Disease [Phase 2]
Phase 2 trial update on TD-1473 for Crohn's disease, terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) [Phase 4]
Phase 4 trial update for an anti-TNF discontinuation strategy in Crohn's disease and inflammatory bowel disease (including ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease [Phase 1, Phase 2]
Phase 1/2 trial summary for repeated IV administration of E6011 in Crohn's disease completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease
A completed clinical trial assessing healthcare resource use, mental health problems, and infections in people with inflammatory bowel disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease [Phase 2]
A Phase 2 trial evaluating a Janssen investigational therapy for moderately to severely active Crohn's disease was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [Phase 3]
Phase 3 trial update for Alicaforsen (ISIS 2302) in active Crohn's disease; study completed.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies [Phase 3]
Phase 3 trial assessing efficacy and safety of upadacitinib in moderately to severely active Crohn's disease after inadequate response or in…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial updating on etrolizumab for moderately to severely active Crohn's disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease [Phase 3]
A Phase 3 clinical trial update evaluating exclusive enteral nutrition in patients with ileocecal Crohn's disease is ongoing, with unclear s…
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients [Phase 4]
Phase 4 clinical trial updating dosing interval of adalimumab in Crohn's disease patients in remission.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease. [Phase 3]
A Phase 3 trial comparing Vedolizumab IV to placebo in Chinese participants with Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Fecal Transplant for Crohn's Disease [Phase 2]
A Phase 2 clinical trial evaluating fecal transplant for Crohn's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Control Crohn Safe Trial [Phase 4]
Phase 4 clinical trial update for Control Crohn Safe Trial investigating Crohn's disease and inflammatory bowel diseases; currently recruiti…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy [Phase 3]
A Phase 3 trial evaluating upadacitinib for moderate-to-severe Crohn's disease in patients inadequately responding or intolerant to biologic…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [Phase 3]
Phase 3 trial update for Alicaforsen (ISIS 2302) in active Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients [Phase 1, Phase 2]
A clinical trial update reports safety data for injection of placental mesenchymal stem cell–derived exosomes in Crohn's-associated perianal…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) [Phase 4]
Phase 4 randomized controlled trial investigating therapeutic escalation for moderate postoperative recurrence in Crohn's disease (POMEROL t…
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy [Phase 4]
Phase 4 randomized trial comparing infliximab-antimetabolites combination therapy to anti-metabolites monotherapy and to infliximab monother…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent [Phase 2]
Phase 2 trial evaluating Lumentin 44 as a diagnostic contrast agent completed for Crohn disease.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial evaluating risankizumab for moderately to severely active Crohn's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment [Phase 3]
Phase 3 trial evaluating risankizumab for moderately to severely active Crohn's disease in patients who failed prior biologic treatment; stu…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease [Phase 2]
Phase 2 trial evaluating filgotinib for fistulizing Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) [Phase 3]
Phase 3 trial of ontamalimab as maintenance treatment in moderate-to-severe Crohn's disease was terminated; results posted in 2022.